Innate Pharma SA Income Statement 2011-2024 | IPHYF

Fifteen years of historical annual and quarterly income statements for Innate Pharma SA (IPHYF).

Annual Data | Millions of US $ except per share data

TTM2023202220212020201920182017201620152014201320122011
$0.00$66.71$60.77$29.23$80.48$96.11$111$49.77$72.73$27.90$10.13$22.11$18.36$16.35
$0.00$0$0$0$0$0$0$0$0$0$21.43$14.17$12.75$15.16
$0.00$66.71$60.77$29.23$80.48$96.11$111$49.77$72.73$27.90$-11.30$7.94$5.61$1.19
$0.00$60.63$54.43$55.61$66.95$88.31$82.14$75.73$53.81$33.19$0.00$0.00$0.00$0.00
$0.00$19.79$23.64$30.20$35.69$28.90$21.43$19.23$10.54$6.67$11.70$10.06$8.56$10.11
$0.00$0$-43.20$0$-48.74$-9.21$-1.31$0$0$0$0$0$0$0
$0.00$0$0$0$0$0$0$0$0$0$14.81$11.22$9.63$11.39
$0.00$-13.71$-60.50$-56.58$-70.91$-30.30$6.08$-45.19$8.38$-11.95$-26.11$-3.28$-4.02$-10.20
$0.00$5.52$-0.58$2.78$-2.18$7.05$-2.87$-9.08$5.94$4.51$0$-0.54$-0.08$0.49
$0.00$-8.19$-61.08$-53.81$-73.09$-23.25$3.21$-54.27$14.32$-7.44$-26.11$-3.84$-4.11$-9.72
$0.00$0$0$0$0$0$-0.39$0.42$0.33$0$0.00$0.00$0.00$0.00
$0.00$-8.19$-61.08$-53.81$-73.09$-23.25$3.60$-54.69$13.99$-7.44$-26.11$-3.84$-4.11$-9.72
$0.00$0$0$0$0$0$0$0$0$0$0.00$0.00$0.00$0.00
$0.00$-8.19$-61.08$-53.81$-73.09$-23.25$3.60$-54.69$13.99$-7.44$-26.12$-3.84$-4.11$-9.72
$0.00$0$-0.14$-8.67$0$0$0$0$0$0$0.00$0.00$0.00$0.00
$0.00$-8.19$-61.22$-62.48$-73.09$-23.25$3.60$-54.69$13.99$-7.44$-26.11$-3.84$-4.11$-9.72
$0.00$-8.20$-12.66$-51.14$-6.03$-11.79$14.82$-40.23$11.99$-9.01$-23.00$-2.12$-2.95$-8.95
$0.00$-13.71$-60.50$-56.58$-70.91$-30.30$6.08$-45.19$8.38$-11.95$-26.11$-3.28$-4.02$-10.20
$0.00$-0.10$-0.77$-0.78$-0.93$-0.35$0.06$-1.01$0.25$-0.14$-0.52$-0.10$-0.11$-0.26
$0.00$-0.10$-0.77$-0.78$-0.93$-0.34$0.06$-1.01$0.25$-0.14$-0.52$-0.10$-0.11$-0.26

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2023-12-312023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312019-06-302018-12-312018-06-302017-12-312016-12-312016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302012-12-312012-06-302011-12-312011-06-30
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00